Development of an intein-mediated split–Cas9 system for gene therapy

Using CRISPR/Cas9, it is possible to target virtually any gene in any organism. A major limitation to its application in gene therapy is the size of Cas9 (>4 kb), impeding its efficient delivery via recombinant adeno-associated virus (rAAV). Therefore, we developed a split–Cas9 system, bypassing...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Dong-Jiunn Jeffery, Kühner, Karin, Kühn, Ralf, Werfel, Stanislas, Engelhardt, Stefan, Wurst, Wolfgang, Ortiz, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513872/
https://www.ncbi.nlm.nih.gov/pubmed/26082496
http://dx.doi.org/10.1093/nar/gkv601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513872/
https://www.ncbi.nlm.nih.gov/pubmed/26082496
http://dx.doi.org/10.1093/nar/gkv601

Ejemplares similares